SCHEMBL19976890

SCHEMBL19976890

CCC(CC)c1ccc(Cl)cc1NN

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.39
HTT P42858 2/20 0.39
TP53 P04637 1/20 0.39
KCNH2 Q12809 1/20 0.38
ALDH1A1 P00352 3/20 0.37
KDM4E B2RXH2 2/20 0.37
RAB9A P51151 1/20 0.37
MAPT P10636 3/20 0.36
GAA P10253 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
IDO1 P14902 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
POLB P06746 1/20 0.34
TAS1R3 Q7RTX0 1/20 0.34
TAS1R1 Q7RTX1 1/20 0.34
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26665293 0.79 HTT (0.47) LMNAHTTTP53ALDH1A1RAB9A
SCHEMBL19976867 0.79 PKM (0.36) KCNH2ALDH1A1MAPTGAAIDO1
SCHEMBL19068767 0.76 HTT (0.34) LMNAHTTTP53KCNH2ALDH1A1
SCHEMBL20856563 0.76 LMNA (0.38) LMNAHTTTP53ALDH1A1KDM4E
SCHEMBL18593511 0.73 KCNH2 (0.41) LMNAHTTTP53KCNH2ALDH1A1
SCHEMBL17247748 0.72 TP53 (0.44) LMNAHTTTP53KCNH2ALDH1A1
SCHEMBL19987482 0.72 KCNH2 (0.47) LMNAHTTTP53KCNH2
SCHEMBL16676250 0.69 DDR1 (0.39) LMNAHTTKCNH2ALDH1A1KDM4E
SCHEMBL20032503 0.69 GCG (0.39) LMNAHTTTP53KCNH2MAPT
SCHEMBL16529426 0.69 CCR2 (0.46) ALDH1A1KDM4ERAB9AMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9920012-B2 Indazole guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2018-03-20 US disclosed